Related Experiment Videos

Weekly platinum chemotherapy for recurrent ovarian cancer

A Clamp, G C Jayson

British Journal of Cancer

|February 22, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Plasma Tie2 trajectories identify vascular response criteria for VEGF inhibitors across advanced biliary tract, colorectal and ovarian cancers.

ESMO open·2022

The impact of olaparib dose reduction and treatment interruption on treatment outcome in the SOLO2/ENGOT-ov21 platinum-sensitive recurrent ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial.

ESMO open·2021

Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903).

Gynecologic oncology·2021

A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer.

Gynecologic oncology·2020

Dealing with loss: food and eating in women with ovarian cancer on parenteral nutrition.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2020

See all related articles